Literature DB >> 1533399

Plasmin generation induces neutrophil aggregation: dependence on the catalytic and lysine binding sites.

T J Ryan1, L Lai, A B Malik.   

Abstract

We established that plasmin (10(-10) M to 10(-6) M) caused neutrophils (PMN) to aggregate using an in vitro assay. Plasminogen had no PMN aggregatory activity even at a concentration of 2 microM. However, plasminogen caused PMN to aggregate when incubated with plasminogen activators [tissue plasminogen activator (25-200 U/ml) or urokinase (5-500 U/ml)]. Tissue plasminogen activator and urokinase alone had no PMN aggregatory activity. Analysis of these incubation mixtures indicated that plasmin was generated in the process and that the time course of plasmin generation correlated with the aggregation response. Active-site-inhibited plasmin did not induce PMN aggregation, indicating that a functional catalytic site was required for the response. Pretreatment of PMN with either active-site-inhibited plasmin or tranexamic acid prevented PMN aggregation by plasmin, indicating that both binding of plasmin to the cell surface via the lysine binding sites and catalysis were required for the response. The generation of plasmin during activation of fibrinolysis may play a pro-inflammatory role by mediating aggregation of PMN.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533399     DOI: 10.1002/jcp.1041510206

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

1.  Neutrophil and Platelet Activity and Quantification Following Delayed tPA Therapy in a Rabbit Model of Thromboembolic Stroke.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  MHJ_0461 is a multifunctional leucine aminopeptidase on the surface of Mycoplasma hyopneumoniae.

Authors:  Veronica M Jarocki; Jerran Santos; Jessica L Tacchi; Benjamin B A Raymond; Ania T Deutscher; Cheryl Jenkins; Matthew P Padula; Steven P Djordjevic
Journal:  Open Biol       Date:  2015-01       Impact factor: 6.411

3.  Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19.

Authors:  Alain R Thierry
Journal:  Physiol Rev       Date:  2020-10-01       Impact factor: 37.312

4.  Thrombin and Plasmin Alter the Proteome of Neutrophil Extracellular Traps.

Authors:  Chun Hwee Lim; Sunil S Adav; Siu Kwan Sze; Yeu Khai Choong; Rathi Saravanan; Artur Schmidtchen
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.